tocophersolan has been researched along with ginsenosides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, J; Jia, X; Lv, H; Sun, E; Wang, J; Xin, J; Yan, H; Yang, L; Zhang, Z | 1 |
| Che, D; Jin, X; Pei, B; Tong, D; Xia, X; Yuan, G; Zhang, Y | 1 |
2 other study(ies) available for tocophersolan and ginsenosides
| Article | Year |
|---|---|
TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drug Carriers; Ginsenosides; Liposomes; Male; Mice, Nude; Panax; Phospholipids; Phytotherapy; Plant Extracts; Polyethylene Glycols; Vitamin E | 2016 |
Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo.
Topics: A549 Cells; Animals; Apoptosis; Ascorbic Acid; Cell Cycle; Cell Movement; Drug Delivery Systems; Endocytosis; Ginsenosides; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Mice, Nude; Micelles; Succinates; Tumor Burden; Vitamin E | 2017 |